Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurice Michel

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Zeitschrift Fur Gastroenterologie|December 8, 2020
[Liver-specific diagnostic for non-alcoholic fatty liver disease (NAFLD) - time to replace liver biopsy?]Maurice Michel, Jörn M Schattenberg
RSC Chemical Biology|April 1, 2026
Facilitated DNA damage repair as an emerging therapeutic strategy for inflammatory and fibrotic diseasesMaurice Michel, Nayere Taebnia, Volker M Lauschke
AIDS (London, England)|November 4, 2023
Development and validation of a multivariable risk prediction model for hepatic steatosis in patients with HIV infectionMarielle Wirth, Christian Ruckes, Maurice Michel, et al.
Frontiers in Oncology|September 5, 2019
Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular CarcinomaMaurice Michel, Marcus Hollenbach, Sabine Pohl, et al.
International Journal of Molecular Sciences|April 30, 2021
NEIL1 and NEIL2 Are Recruited as Potential Backup for OGG1 upon OGG1 Depletion or Inhibition by TH5487Bishoy M F Hanna, Maurice Michel, Thomas Helleday, et al.
DNA Repair|October 22, 2025
Modulation of OGG1 enzymatic activity by the cellular machinery - have all the boxes been ticked?Alice Eddershaw, Natálie Rudolfová, Holly Dawson, et al.
Cancers|June 2, 2021
The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for TherapyMaurice Michel, Leonard Kaps, Annett Maderer, et al.
Plos One|February 24, 2017
Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosisMarcus Hollenbach, Antje Thonig, Sabine Pohl, et al.
Expert Review of Molecular Diagnostics|July 28, 2023
Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver diseaseAngelo Armandi, Maurice Michel, Kamela Gjini, et al.
Nutrients|March 11, 2020
Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)Anika Nier, Yvonne Huber, Christian Labenz, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Zeitschrift Fur Gastroenterologie|December 8, 2020
[Liver-specific diagnostic for non-alcoholic fatty liver disease (NAFLD) - time to replace liver biopsy?]Maurice Michel, Jörn M Schattenberg
RSC Chemical Biology|April 1, 2026
Facilitated DNA damage repair as an emerging therapeutic strategy for inflammatory and fibrotic diseasesMaurice Michel, Nayere Taebnia, Volker M Lauschke
AIDS (London, England)|November 4, 2023
Development and validation of a multivariable risk prediction model for hepatic steatosis in patients with HIV infectionMarielle Wirth, Christian Ruckes, Maurice Michel, et al.
Frontiers in Oncology|September 5, 2019
Inhibition of Glyoxalase-I Leads to Reduced Proliferation, Migration and Colony Formation, and Enhanced Susceptibility to Sorafenib in Hepatocellular CarcinomaMaurice Michel, Marcus Hollenbach, Sabine Pohl, et al.
International Journal of Molecular Sciences|April 30, 2021
NEIL1 and NEIL2 Are Recruited as Potential Backup for OGG1 upon OGG1 Depletion or Inhibition by TH5487Bishoy M F Hanna, Maurice Michel, Thomas Helleday, et al.
DNA Repair|October 22, 2025
Modulation of OGG1 enzymatic activity by the cellular machinery - have all the boxes been ticked?Alice Eddershaw, Natálie Rudolfová, Holly Dawson, et al.
Cancers|June 2, 2021
The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for TherapyMaurice Michel, Leonard Kaps, Annett Maderer, et al.
Plos One|February 24, 2017
Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosisMarcus Hollenbach, Antje Thonig, Sabine Pohl, et al.
Expert Review of Molecular Diagnostics|July 28, 2023
Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver diseaseAngelo Armandi, Maurice Michel, Kamela Gjini, et al.
Nutrients|March 11, 2020
Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)Anika Nier, Yvonne Huber, Christian Labenz, et al.
Pageof 7